Karen Long

Ms. Long is the Managing Director of KCK MedTech. KCK focuses capital investment on highly disruptive therapies within the medical device sector. Ms. Long has been with KCK since January 2018 when she joined as Executive-in-Residence. Within KCK, she serves as Board Director at Revelle Aesthetics, Candesant BioMedical, LungPacer Medical, and Barologics, as well as Chairman of the Board of Aerin Medical and Sonex Health. Prior to KCK, Ms. Long was President and CEO of Nuelle, a women’s consumer health company incubated at ExploraMed beginning in 2012. Nuelle was acquired in 2017 by Aytu. In early 2007, she joined Acclarent as Worldwide Vice President of Marketing. Acclarent was acquired in late 2010 by Johnson & Johnson. She remained with J&J until 2012 when she left to join Nuelle. Acclarent was also an early spinout from ExploraMed. Ms. Long has spent over 20 years in medical devices and diagnostics developing and marketing novel and market-leading products focused on improving quality of life. She held a series of key operating roles in ChemTrak and Inverness Medical, and management positions at LifeScan after the acquisition of Inverness Medical by J&J. Ms. Long began her career as a Licensed Clinical Social Worker after receiving her undergraduate and graduate degrees from San Diego State University.